FDA Approved: LYNPARZA — Supplemental Application (AstraZeneca Pharmaceuticals LP)

View source ↗

Summary

The FDA approved a supplemental application for LYNPARZA (olaparib) from AstraZeneca Pharmaceuticals LP, resulting in changes to the product's labeling and/or i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Fallopian Tube Cancer
• Ovarian Cancer
• Pancreatic Cancer
• Peritoneal Cancer
• Prostate Cancer

Drugs mentioned

• Lynparza (olaparib)

Snippet

SUPPL AP for LYNPARZA (OLAPARIB)